Background: Apoplexia cerebri, brain stroke, is a common illness that effects 12 000 people in Norway each year and is a main cause of serious dysfunction. Today there are several hospitals with stroke units that specialize in acute treatment of stroke. It is important for the stroke units to monitor the treatment. In this article we describe a group of patients that got reperfusion treatment at Ullevål, OUS. Material and method: The patient material is assembled from the local quality register at the stroke unit at Ullevål and includes all the patients that got reperfusion treatment, either intravenous alteplase or trombectomy, between November 2009 and January 2011. A standard form filled out by personal at the stroke unit included the kind of treatment the patient received, indicators of patient s health and function (i.e. NIHSS and mRs) as well as general information about the patient. Results: The material consisted of 35 patients, 14 (40 %) women and a median age of 68 years. 8 patients (23 %) had a previous stroke or TIA. 26 (74 %) were treated with intravenous alteplase, the rest with trombectomy. 19 patients (54 %) were classified with PACS, 7 (20 %) with TACS, 6 (17 %) with POCS and 3 patients (9 %) with LACS. At arrival to the stroke unit the mean NIHSS-score were 9, 7 after one day and 4 when the patients were discharged. They had a NIHSS-score at 10,9 right before the reperfusion treatment and 8,6 right after. The mean door-to-needle time was 60 minutes. 2 patients (6 %) died (mRs-score 6), 15 (45 %) had a mRs-score of 0-1 on the day of discharge, 6 (18 %) had mRs-score 2-3 and 10 (30 %) a mRs-score of 4-5. Discussion: The patient material is small (n=35) and only one of our analysis got a statistic significant p-value. The results cannot be generalized to the general stroke population. The two patients that died were both over the age of 77, they both had poor effect of the reperfusion treatment and they were both classified with TACS. The stroke unit at Ullevål could benefit of having a more complete register and include more variables such as complications due to the treatment. It would be useful to investigate a bigger patient material and evaluate the results at Ullevål compared to international studies.